Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment in Primary Biliary Cholangitis Using Invasive Markers

NCT07122206 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT07122206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring the Response of Combination Ursodiol and Seladelpar Treatment in Primary Biliary Cholangitis Using Invasive Markers
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
August 31, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis